Clinical Trials

Hematologic Neoplasms

NCT04955938 2024-07-31

A Study of Fedratinib With IDH Inhibition in Advanced-Phase, IDH-Mutated Ph-Negative Myeloproliferative Neoplasms

MyeloidOther hematologic neoplasm

Leukemia, Myeloproliferative Disorders, Hematologic Neoplasms

NCT05403580 2024-05-06

Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Patients With Advanced Cancer

Phase 3 Withdrawn

Hematologic Neoplasms

NCT04684979 2023-11-01

Transplantation of Hematopoietic Stem Cells From HLA-compatible Donors in Patients With B-Cell Lymphoid Malignancies

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Hematologic Neoplasms

NCT03688789 2023-03-31

HemaSur

Hematologic Neoplasms

NCT05038384 2023-03-31

Palliative, Rehabilitation, and Integrated Medicine Handbook for Self Care at Work

Hematologic Neoplasms

NCT04282174 2022-09-27

2019-KOE-001

LymphoidMyeloidOther hematologic neoplasm

Hematologic Diseases, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04138875 2022-06-23

A Risk Stratified Sequential Treatment With Rituximab, Brentuximab Vedotin and Bendamustine (RBvB)

Infectious Mononucleosis, Hematologic Neoplasms

NCT04605614 2022-06-09

64Cu-DOTA-pembrolizumab PET for the Study of PD1 Expression

Phase EARLY_PHASE1 Withdrawn

Hematologic Neoplasms

NCT04803630 2022-05-12

Thermal Therapy for the Treatment of Depression in Cancer Survivors, the S-WARM Study

Hematologic Neoplasms

NCT04390542 2021-07-20

Intervention for Caregivers of Patients Undergoing HSCT or CAR T-cell Therapy

Hematologic Neoplasms

NCT04455958 2021-04-26

Lopinavir/Ritonavir for the Treatment of COVID-19 Positive Patients With Cancer and Immune Suppression in the Last Year

Hematologic Neoplasms

NCT03804164 2020-12-17

Psycho-Educational Cognition Intervention in Patients With Blood and Lymph Cancer

Hematologic Neoplasms

NCT04127721 2020-10-29

Itacitinib for the Prevention of Graft Versus Host Disease in Patients Undergoing Donor Stem Cell Transplantation

Hematologic Diseases, Hematologic Neoplasms

NCT04392128 2020-09-04

HYACINTHE

COVID-19, Hematologic Neoplasms

NCT04016116 2020-05-27

Dual PD-1 and JAK2 Inhibition in Hematological Malignancies

Neoplasms, Hematologic Neoplasms

NCT03986086 2020-03-20

MPH966 for Prevention of Graft-versus-host Disease After Allogeneic Hematopoietic Stem Cell Transplantation

Hematologic Neoplasms

NCT03531281 2018-12-07

Human Lysozyme Goat Milk in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant

Hematologic Neoplasms

NCT03086252 2018-07-26

Patient-Driven Transfusion Thresholds in Hematological Disorders: A Pilot Study

Classical hematologyMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Anemia, Aplastic, Leukemia, Myelodysplastic Syndromes, Hematologic Neoplasms

NCT02718755 2018-06-26

Phase II Study of Fludarabine, Cytarabine (ARA-C) and Erwinase IV in Patients With Relapsed or Refractory Hematologic Malignancies

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Lymphoma, Recurrence, Leukemia, Biphenotypic, Acute, Leukemia, Prolymphocytic, Leukemia, Myeloid, Acute, Lymphoma, B-Cell, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01163201 2017-12-02

T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic Malignancies

Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Burkitt Lymphoma, Lymphoma, Follicular, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Lymphoma, B-Cell, Marginal Zone, Hematologic Neoplasms, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02118311 2017-12-02

Treg Cells for AGVHD in Non-myeloablative UCB Transplant

LymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

Burkitt Lymphoma, Hodgkin Disease, Lymphoma, Follicular, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Lymphoma, B-Cell, Marginal Zone, Hematologic Neoplasms, Lymphoma, Mantle-Cell, Dendritic Cell Sarcoma, Interdigitating

NCT02087787 2017-11-06

Medical-legal Partnership (MLP) to Support Bone Marrow Transplant

Hematologic Neoplasms

NCT02343679 2017-02-01

Novartis PhII Ceritinib (LDK378) in R/R ALK+ Hem Malignancies

Hematologic Neoplasms

NCT01326273 2015-06-08

Autologous Cytomegalovirus (CMV) Specific CD8+ T Cells as Treatment for CMV Reactivation

Leukemia, Hematologic Neoplasms

NCT01336478 2015-06-08

CD56+CD3- NK Cells Following Allogeneic Stem Cell Transplantation

Leukemia, Hematologic Neoplasms

NCT00899808 2015-05-29

Molecular Markers and Genetic Markers in Patients Undergoing Radiation Therapy for Cancer

Hematologic Neoplasms

NCT01988701 2015-03-02

Lymphocyte Profiles and Activation Status in Patients With Graft-Versus-Host Disease

Bronchiolitis Obliterans Syndrome, Graft vs Host Disease, Hematologic Neoplasms

NCT02207764 2014-12-23

Reiki as a Complementary Therapy: A Pilot Study

Hematologic Neoplasms

NCT00731705 2014-09-19

In-Vitro Studies in Depletion of Haplotype Mismatched Alloreactive T Cells

Hematologic Neoplasms

NCT01620229 2014-04-21

Brentuximab Vedotin After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Hematologic Neoplasms

NCT01247688 2013-12-12

UCALL

Hematologic Neoplasms

NCT00737191 2012-03-09

Opioids With or Without Olanzapine in Treating Patients With Moderate to Severe Cancer Pain

Pain, Hematologic Neoplasms

NCT01131247 2011-07-20

PH2 Trial in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) With a Combination of Bendamustine & Ofatumumab

LymphoidOther hematologic neoplasm

37 enrolled

Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Hematologic Neoplasms

NCT00149032 2011-04-08

Treatment of Patients With Donor Lymphocytes Sensitized by Antigens Expressed by the Host

50 enrolled